2022 -now Vice President of Rare and Orphan Diseases @
2020 -now SGE Drug Safety and Risk Management Advisory (DSaRM) Committee @
2011 -now Clinical Associate Professor @
2018 -2022 Senior Vice President of Clinical and Scientific Affairs @
2015 -2018 Director of Research Support Services @ Ascension Texas (Seton Family Hospitals, Dell Children's Medical Center, Provide
2011 -2015 Director of Research and Research Integrity @
2010 -2015 SGE FDA Advisor CNS and PNS @
2006 -2011 Clinical Neuropharmacologist and Professor Lab Director @ UT Health Science Center
2006 -2011 Asst and Associate Professor Pharmacy @
2003 -2006 Associate Director of Research and Clinical Pharmacologist @
2000 -2003 Clinical Pharmacologist Research Manager @
Collin Hovinga Education
UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences 2012-2013
The University of Tennessee Health Science Center 2009-2011
FDA 2009-2010
UT Health Science Center LeBonheur Children's Medical Center 1998-2000
UT Health Science Center, LeBonheur Childrens 1997-1998
Creighton University 1987-1991
Collin Hovinga Summary
Collin Hovinga, based in Austin, TX, US, is currently a Vice President of Rare and Orphan Diseases at Critical Path Institute (C-Path). Collin Hovinga brings experience from previous roles at FDA, The University of Texas at Austin, College of Pharmacy, Institute for Advanced Clinical Trials for Children (I-ACT for Children) and Ascension Texas (Seton Family Hospitals, Dell Children's Medical Center, Provide. Collin Hovinga holds a 2012 - 2013 UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences. Collin Hovinga has 3 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.